Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies

BACKGROUND: Proportionate female representation in health research is necessary for scientific rigor and health equity. We aimed to assess the representation of women in clinical trials leading to U.S. Food and Drug Administration (FDA) cancer drug approvals. MATERIALS AND METHODS: Trials supporting...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Mendis, Shehara, Anand, Seerat, Karasinska, Joanna M., Dasari, Arvind, Unger, Joseph M., Gothwal, Anirudh, Ellis, Lee M., Varadhachary, Gauri, Kopetz, Scott, Overman, Michael J., Raghav, Kanwal, Loree, Jonathan M.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2020
Témata:
Community Outreach
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873318/
https://ncbi.nlm.nih.gov/pubmed/32960478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13534
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky